Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.

Dylan Lewis: We're talking three stocks down bad. Motley Fool Money starts down. I'm Dylan Lewis, I'm joined over the ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

Yesterday the World Health Organization (WHO) said Tanzania has 1 confirmed case of Marburg and 25 suspected cases all from ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Vaccinations for flu and COVID-19 in Chicago are down from last year, according to a report by local health officials.